Ascus Biosciences

About:

Ascus Biosciences uses novel microbial community screening methods to discover, develop, and commercialize next generation feed additives.

Website: http://www.ascusbiosciences.com

Top Investors: Temasek Holdings, Anterra Capital, Formation 8, Cavallo Ventures

Description:

Ascus Biosciences develops computational and genomics-based technology platform to discover and develop next-generation microbial products. The company was founded in 2015 and is headquartered in San Diego, California.

Total Funding Amount:

$51M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2015-03-01

Contact Email:

info(AT)ascusbiosciences.com

Founders:

Karsten Zengler, Karsten Zengler PhD, Mallory Embree, Michael Seely

Number of Employees:

11-50

Last Funding Date:

2020-05-27

IPO Status:

Private

Industries: